Peer-led Personalized Support Program

NCT05918601 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-05-31

No results posted yet for this study

Summary

Aim: To test the effectiveness of a peer-led personalized support program using instant messaging applications and a self- determination theory-based intervention to help young drug abusers quit drugs.

Hypothesis to be tested: The investigators hypothesize that compared with those in the control group, the participants in the intervention group will experience greater success in reducing and quitting drugs and will have a better health-related quality of life at 12 months follow-up.

Conditions

  • Health-risk Behaviours
  • Drug Abuse

Interventions

OTHER

Health-risk behaviors

Participants will be asked about the priority they place on engagement in health-related lifestyles, such as quitting drugs, alcohol, smoking or exercising regularly.

OTHER

Theory of planned behavior, Self-determination theory

The participants will be asked to quit drugs immediately or progressively with the ultimate goal of quitting drugs completely.

OTHER

Assist them to adhere to their schedule of quitting drugs throughout the study period

The participants will receive instant messaging via WeChat or WhatsApp from peer supporters to assist them to adhere to their schedule of quitting drugs throughout the study period.

OTHER

Assist them to adhere to their schedule of desirable health-related lifestyles/quitting drugs throughout the study period

The participants will receive instant messaging via WeChat or WhatsApp from peer supporters to assist them to adhere to their schedule of desirable health-related lifestyles/quitting drugs throughout the study period.

OTHER

(AWARD) model

Participants receive a brief intervention using the Ask, Warn, Advise, Refer and Do-it-Again (AWARD) model

OTHER

Receive four independent 1-minute videos

The participants will receive four independent 1-minute videos which focus on the health risks associated with abusing drugs and the benefits of quitting drugs.

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Ho Cheung William Li · Chinese University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05918601 on ClinicalTrials.gov